ZIC2 and lip and oral cavity carcinoma: It was predicted that oral cancer patients with relatively higher ZIC2 expression were more sensitive to two compounds including AZD8186 and ERK_2240 than oral cancer patients with lower ZIC2 expression (P < 0.05) (Figure 12).